Published ahead of print on January 17, 2008, doi:10.1164/rccm.200709-1332OC
© 2008 American Thoracic Society doi: 10.1164/rccm.200709-1332OC
Longitudinal Change in FEV1 and FVC in Chronic Spinal Cord Injury1 Research and Development Service, Department of Veterans Affairs, VA Boston Healthcare System, Boston, Massachusetts; 2 Programs in Research at VA Boston, Harvard Medical School, West Roxbury, Massachusetts; 3 VA Cooperative Studies Program, VA Boston Healthcare System, Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts; 4 Pulmonary and Critical Care Medicine Unit and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; 5 Harvard Medical School, Boston, Massachusetts; 6 Rehabilitation Medicine Service, VA Boston Healthcare System and Harvard Medical School, Boston, Massachusetts; 7 Pulmonary and Critical Care Medicine Section, Medical Service, VA Boston Healthcare System, Boston, Massachusetts; and 8 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts Correspondence and requests for reprints should be addressed to Eric Garshick, M.D., M.O.H., VA Boston Healthcare System, Pulmonary and Critical Care Medicine Section, 1400 VFW Parkway, West Roxbury, MA 02132. E-mail: eric.garshick{at}va.gov Rationale: Although respiratory dysfunction is common in chronic spinal cord injury (SCI), determinants of longitudinal change in FEV1 and FVC have not been assessed. Objectives: Determine factors that influence longitudinal lung function decline in SCI. Methods: A total of 174 male participants (mean age of 49 and 17 yr after injury) completed a respiratory questionnaire and underwent spirometry over an average follow-up of 7.5 years (range, 4–14 yr). Measurements and Main Results: In multivariate models, longitudinal decline in FEV1 was significantly related to continued smoking, persistent wheeze, an increase in body mass index, and respiratory muscle strength. Aging was associated with an accelerated decline in FEV1 (for ages <40, 40–60, >60 yr: –27, –37, and –71 ml/yr, respectively). Similar effects were observed for FVC. Conclusions: Longitudinal change in FEV1 and FVC was not directly related to level and severity of SCI, but was attributable to potentially modifiable factors in addition to age. These results suggest that weight control, smoking cessation, trials directed at the recognition and treatment of wheeze, and efforts to improve respiratory muscle strength may slow lung function decline after SCI.
Key Words: respiratory function longitudinal studies smoking body mass index
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||